This historical foundation has been further reinforced by the NIA–AA ATN research model, which redefines AD as a biological construct, classifying individuals according to biomarkers of Aβ deposition (A), pathologic tau protein (T), and neurodegeneration (N). The gene discussed is MAPT; the disease is Alzheimer disease.